What is the prognosis of bladder cancer

The five-year survival rate is usually used to evaluate the prognosis of malignant tumors. If the bladder cancer does not infiltrate the bladder muscle layer, the five-year survival rate of the patient can reach 91.9%. The five-year survival rate of bladder cancer patients who have invaded the muscle layer will drop to 84.3%. The prognosis of bladder cancer depends on the stage and grade of the tumor itself. The tumor grade is generally divided into three levels of malignancy: high, medium, and low. When the tumor invades the superficial muscle layer, the chance of metastasis is 12%. When it passes through the muscle layer and has peripheral infiltration, 74% of patients will have regional lymph node and blood metastasis, and the prognosis is very poor, with a cure rate of only 26%.

Complications after bladder cancer surgery

Radical cystectomy, early complications mainly include bladder bleeding, effusion, infection, pelvic infection, lymph leakage, urine leakage, intestinal leakage, etc. Anastomotic leakage. Postoperative complications of bladder tumors are related to the surgical method and personal constitution.

How many days after bladder cancer surgery can I be discharged from the hospital?

The time to be discharged from the hospital after bladder cancer surgery varies from person to person, depending on the patient's physical condition, wound healing, and treatment effect. Regular follow-up examinations are required after surgery to control cancer cells, prevent the spread of cancer cells, and increase the burden on the body. Patients should rest, drink plenty of water, and eat more fresh vegetables and fruits. Bladder cancer surgery depends on the specific surgical situation. Generally, the recovery is faster for bladder tumor electroresection, and patients are usually discharged about 3 days after surgery. If bladder cancer is radically cured, the recovery time will be longer, and patients may need to be discharged about 7 days after surgery. Bladder cancer is a common malignant tumor of the urinary system.